UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 180 filers reported holding UNIQURE NV in Q2 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $10,484,708 | -18.0% | 914,896 | +44.2% | 0.01% | -25.0% |
| Q1 2023 | $12,780,038 | +200151.3% | 634,560 | +125.4% | 0.02% | +77.8% |
| Q4 2022 | $6,382 | -99.8% | 281,530 | +32.8% | 0.01% | +50.0% |
| Q3 2022 | $3,976,000 | +29.6% | 211,930 | +28.8% | 0.01% | +50.0% |
| Q2 2022 | $3,067,000 | +43.6% | 164,535 | +39.2% | 0.00% | +100.0% |
| Q1 2022 | $2,136,000 | +20.1% | 118,203 | +37.8% | 0.00% | 0.0% |
| Q4 2021 | $1,779,000 | – | 85,797 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |